Terms: = Breast cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG AND Treatment
13 results:
1. PPARγ antagonists induce aromatase transcription in adipose tissue cultures.
Ardenkjær-Skinnerup J; Saar D; Petersen PSS; Pedersen M; Svingen T; Kragelund BB; Hadrup N; Ravn-Haren G; Emanuelli B; Brown KA; Vogel U
Biochem Pharmacol; 2024 Apr; 222():116095. PubMed ID: 38423186
[TBL] [Abstract] [Full Text] [Related]
2. Fabrication of a Coculture Organoid Model in the Biomimetic Matrix of Alginate to Investigate breast cancer Progression in a TAMs-Leading Immune Microenvironment.
Xu NY; Li J; Wang ML; Chen XY; Tang R; Liu XQ
ACS Appl Mater Interfaces; 2024 Mar; 16(9):11275-11288. PubMed ID: 38383056
[TBL] [Abstract] [Full Text] [Related]
3. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation.
Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM
Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037
[TBL] [Abstract] [Full Text] [Related]
4. breast cancer Stem Cells-derived Extracellular Vesicles Affect pparg Expression by Delivering MicroRNA-197 in breast cancer Cells.
Li L; Xiong Y; Wang N; Zhu M; Gu Y
Clin Breast Cancer; 2022 Jul; 22(5):478-490. PubMed ID: 35279406
[TBL] [Abstract] [Full Text] [Related]
5. Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.
Van Poznak C; Reynolds EL; Estilo CL; Hu M; Schneider BP; Hertz DL; Gersch C; Thibert J; Thomas D; Banerjee M; Rae JM; Hayes DF
Oral Dis; 2022 Jan; 28(1):193-201. PubMed ID: 33274559
[TBL] [Abstract] [Full Text] [Related]
6. miR-449a Suppresses Tamoxifen Resistance in Human breast cancer Cells by Targeting ADAM22.
Li J; Lu M; Jin J; Lu X; Xu T; Jin S
Cell Physiol Biochem; 2018; 50(1):136-149. PubMed ID: 30278449
[TBL] [Abstract] [Full Text] [Related]
7. High-efficient Screening Method for Identification of Key Genes in breast cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract] [Full Text] [Related]
8. Effects of Pulsed Electromagnetic Fields on breast cancer Cell Line MCF 7 Using Absorption Spectroscopy.
Alcantara DZ; Soliman IJS; Pobre RF; Naguib RNG
Anticancer Res; 2017 Jul; 37(7):3453-3459. PubMed ID: 28668834
[TBL] [Abstract] [Full Text] [Related]
9. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
[TBL] [Abstract] [Full Text] [Related]
10. Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.
Garattini E; Bolis M; Gianni' M; Paroni G; Fratelli M; Terao M
Oncotarget; 2016 Jul; 7(27):42661-42682. PubMed ID: 26894976
[TBL] [Abstract] [Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone.
Nava-Villalba M; Nuñez-Anita RE; Bontempo A; Aceves C
Mol Cancer; 2015 Sep; 14():168. PubMed ID: 26376791
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like breast cancer Based on Functional Differences Using Pathway Analysis.
Wu T; Wang X; Li J; Song X; Wang Y; Wang Y; Zhang L; Li Z; Tian J
PLoS One; 2015; 10(6):e0131183. PubMed ID: 26126114
[TBL] [Abstract] [Full Text] [Related]
13. Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers.
Yee LD; Williams N; Wen P; Young DC; Lester J; Johnson MV; Farrar WB; Walker MJ; Povoski SP; Suster S; Eng C
Clin Cancer Res; 2007 Jan; 13(1):246-52. PubMed ID: 17200362
[TBL] [Abstract] [Full Text] [Related]
